Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

OLK - Olink Holding AB (publ)

Close
0   0%

Share volume: 0
Last Updated:
Analytical Laboratory Instrument Manufacturing : -7.53%

PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
0%
Profitability 0%
Dept financing 0%
Liquidity 0%
Performance 0%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
2.39%
1 Year
3.62%
2 Year
5.42%
Key data
Stock price
N/A
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$21.98 - $26.09
52 WEEK CHANGE
$3.57
MARKET CAP 
2.031 B
YIELD 
N/A
SHARES OUTSTANDING 
122.955 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
1.71
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
N/A
AVERAGE 30 VOLUME 
N/A
Company detail
CEO: Jon Aron Olof Heimer
Region: US
Website: olink.com
Employees: 420
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Analytical Laboratory Instrument Manufacturing
Sector: Manufacturing

Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases. Olink Focus product line consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. The company was founded in 2004 and is headquartered in Uppsala, Sweden.

Recent news